. 2018 Oct-Dec;39(4):213–219. doi: 10.4103/ayu.AYU_147_18

Table 3.

Comparison of results of Apamarga Kshara application (AKA) and group-SCL (sclerotherapy): (n=50)

Symptom	Time period	Mean		Mean Diff.	% Relief		W	P	Significance

		AKA	SCL		AKA	SCL
Bleeding per rectum	7^th day	1.56	1.32	0.24	78	66	265.5	0.312	NS
	14^th day	2	1.48	0.52	100	74	150	<0.001	HS
	21st day	2	2	00	100	100	312	<0.001	HS
	28^th day	2	2	00	100	100	312	<0.001	HS
Painful defecation	7^th day	0.84	0.32	0.52	84	32	192	0.005	HS
	14^th day	0.92	0.48	0.44	92	48	175	<0.001	HS
	21st day	0.96	0.84	0.12	96	84	275	0.167	NS
	28^th day	0.96	0.92	0.04	96	92	300	0.571	NS
Prolapse of piles	7^th day	1.32	0.64	0.68	66	32	136	<0.001	HS
	14^th day	1.92	1.16	0.76	96	58	75	<0.001	HS
	21st day	1.96	1.32	0.64	98	66	112.5	<0.001	HS
	28^th day	2	1.84	0.16	100	92	262.5	0.041	HS
Discharge per rectum	7^th day	0.08	0.64	0.56	66.67	80	441.5	0.002	HS
	14^th day	0.12	0.8	0.68	100	100	437	0.003	HS
	21st day	0.12	0.8	0.68	100	100	437	0.003	HS
	28^th day	0.12	0.8	0.68	100	100	437	0.003	HS
Size of piles	7^th day	0.84	0.36	0.48	42	18	162.5	<0.001	HS
	14^th day	1.44	0.84	0.6	72	42	147	<0.001	HS
	21^st day	1.92	1.32	0.6	96	66	125	<0.001	HS
	28^th day	2	1.88	0.12	100	94	275	0.081	NS

AKA: Apamarga Kshara application, SCL: Sclerotherrapy, W: Wilcoxon signed rank test, P: Probability, HS: Highly Significant, NS: Non Significant